Dar es Salaam. The government said yesterday that it was closely monitoring the recently developed malaria vaccine that has proved to be ‘highly effective’ in clinical trials. The vaccine, developed by scientists at the Jenner Institute of Oxford University, showed up to 77 percent efficacy in a trial of 450 children in Burkina Faso over a period of 12 months. The Guardian (UK) reported that the vaccine holds out the real possibility of slashing.
ON THE GO
Ehanire: Nigeria needs N352bn to tackle malaria in 2021 Osagie Ehanire, minister of health, says the country needs N352 billion to implement its strategic plan to tackle malaria in 2021.Advertisement According to the World Health Organisation 2020 report on.
Ryan Giggs charged with assaulting two women Ryan Giggs, former Manchester United player, has been charged to court for allegedly assaulting two women late last year.Advertisement The embattled Wales manager was also charged with coercive or controlling.
ECWA to Buhari: Use your remaining years in office to redeem Nigeria The Evangelical Church Winning All (ECWA) has urged President Muhammadu Buhari to work towards preventing Nigeria from falling into chaos as a result of insecurity.Advertisement The church’s position was contained.
The vaccine will be manufactured at large scale and low-cost, say the researchers, who have arranged a deal with the Serum Institute of India, which is involved in manufacturing the Oxford/AstraZeneca Covid-19 vaccine.
The Serum Institute has had to delay supplies of the Covid vaccine to the rest of the world because of the huge rise in cases in India, but has promised to deliver 200m doses a year of the malaria vaccine if it is licensed.
Hill said the best-case scenario was approval by the end of 2022, by which time the Serum Institute would have plenty of capacity.
Oxford Malaria vaccine proves highly effective in Burkina Faso trial
7 hours ago|Los Angeles, United States
Early trials show Oxford developers may have finally found an effective jab against the disease.
4 hours ago|United Kingdom
Oxford Malaria vaccine proves highly effective in Burkina Faso trial
Vaccine developed by scientists at Jenner Institute, Oxford, shows up to 77% efficacy in trial over 12 monthsA vaccine against malaria has been shown to be highly effective in trials in Africa, holding out the real possibility of slashing the death toll of a disease that kills 400,000 mostly small children every year.The vaccine, developed by scientists at the Jenner Institute of Oxford University, showed up to 77% efficacy in a trial of 450 chi…